Identification of carcinogenesis and tumor progression processes in pancreatic ductal adenocarcinoma using high-throughput proteomics

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with an overall 5-year survival rate of just 5%. A better understanding of the carcinogenesis processes and the mechanisms of the progression of PDAC is mandatory. Fifty-two PDAC patients treated with surgery and adjuvant therapy, with...

Descripción completa

Detalles Bibliográficos
Autores: Trilla Fuertes, Lucía, Gámez Pozo, Angelo, Lumbreras-Herrera, María Isabel, López-Vacas, Rocío, Heredia-Soto, Victoria, Ghanem, Ismael, López-Camacho, Elena, Zapater-Moros, Andrea, Miguel, María, Pena Burgos, Eva Manuela, Palacios, Elena, de Uribe, Marta, Guerra, Laura, Dittmann, Antje, Mendiola, Marta, Vara, Juan Ángel Fresno, Feliú Batlle, Jaime
Tipo de recurso: artículo
Fecha de publicación:2022
País:España
Institución:Universidad Autónoma de Madrid
Repositorio:Biblos-e Archivo. Repositorio Institucional de la UAM
Idioma:inglés
OAI Identifier:oai:repositorio.uam.es:10486/707566
Acceso en línea:http://hdl.handle.net/10486/707566
https://dx.doi.org/10.3390/cancers14102414
Access Level:acceso abierto
Palabra clave:carcinogenesis
high-throughput proteomics
molecular profiles
pancreatic ductal adenocarcinoma
tumor progression
Medicina
id ES_a5faefa1fc7db2e7d2094f7aa14c0332
oai_identifier_str oai:repositorio.uam.es:10486/707566
network_acronym_str ES
network_name_str España
repository_id_str
spelling Identification of carcinogenesis and tumor progression processes in pancreatic ductal adenocarcinoma using high-throughput proteomicsTrilla Fuertes, LucíaGámez Pozo, AngeloLumbreras-Herrera, María IsabelLópez-Vacas, RocíoHeredia-Soto, VictoriaGhanem, IsmaelLópez-Camacho, ElenaZapater-Moros, AndreaMiguel, MaríaPena Burgos, Eva ManuelaPalacios, Elenade Uribe, MartaGuerra, LauraDittmann, AntjeMendiola, MartaVara, Juan Ángel FresnoFeliú Batlle, Jaimecarcinogenesishigh-throughput proteomicsmolecular profilespancreatic ductal adenocarcinomatumor progressionMedicinaPancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with an overall 5-year survival rate of just 5%. A better understanding of the carcinogenesis processes and the mechanisms of the progression of PDAC is mandatory. Fifty-two PDAC patients treated with surgery and adjuvant therapy, with available primary tumors, normal tissue, preneoplastic lesions (PanIN), and/or lymph node metastases, were selected for the study. Proteins were extracted from small punches and analyzed by LC-MS/MS using data-independent acquisition. Proteomics data were analyzed using probabilistic graphical models, allowing functional characterization. Comparisons between groups were made using linear mixed models. Three proteomic tumor subtypes were defined. T1 (32% of patients) was related to adhesion, T2 (34%) had metabolic features, and T3 (34%) presented high splicing and nucleoplasm activity. These proteomics subtypes were validated in the PDAC TCGA cohort. Relevant biological processes related to carcinogenesis and tumor progression were studied in each subtype. Carcinogenesis in the T1 subtype seems to be related to an increase of adhesion and complement activation node activity, whereas tumor progression seems to be related to nucleoplasm and translation nodes. Regarding the T2 subtype, it seems that metabolism and, especially, mitochondria act as the motor of cancer development. T3 analyses point out that nucleoplasm, mitochondria and metabolism, and extracellular matrix nodes could be involved in T3 tumor carcinogenesis. The identified processes were different among proteomics subtypes, suggesting that the molecular motor of the disease is different in each subtype. These differences can have implications for the development of future tailored therapeutic approaches for each PDAC proteomics subtypeThis research was funded by EPIC-XS, project number 823839, the Horizon 2020 programme of the European Union, and ISCIII PI18/01604MDPIDepartamento de MedicinaFacultad de Medicina20222022-05-13research articlehttp://purl.org/coar/resource_type/c_2df8fbb1VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10486/707566https://dx.doi.org/10.3390/cancers14102414reponame:Biblos-e Archivo. Repositorio Institucional de la UAMinstname:Universidad Autónoma de MadridInglésengEuropean Commission http://dx.doi.org/10.13039/501100000780 Horizon 2020 Framework Programme 823839open accesshttp://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessoai:repositorio.uam.es:10486/7075662026-06-23T12:46:27Z
dc.title.none.fl_str_mv Identification of carcinogenesis and tumor progression processes in pancreatic ductal adenocarcinoma using high-throughput proteomics
title Identification of carcinogenesis and tumor progression processes in pancreatic ductal adenocarcinoma using high-throughput proteomics
spellingShingle Identification of carcinogenesis and tumor progression processes in pancreatic ductal adenocarcinoma using high-throughput proteomics
Trilla Fuertes, Lucía
carcinogenesis
high-throughput proteomics
molecular profiles
pancreatic ductal adenocarcinoma
tumor progression
Medicina
title_short Identification of carcinogenesis and tumor progression processes in pancreatic ductal adenocarcinoma using high-throughput proteomics
title_full Identification of carcinogenesis and tumor progression processes in pancreatic ductal adenocarcinoma using high-throughput proteomics
title_fullStr Identification of carcinogenesis and tumor progression processes in pancreatic ductal adenocarcinoma using high-throughput proteomics
title_full_unstemmed Identification of carcinogenesis and tumor progression processes in pancreatic ductal adenocarcinoma using high-throughput proteomics
title_sort Identification of carcinogenesis and tumor progression processes in pancreatic ductal adenocarcinoma using high-throughput proteomics
dc.creator.none.fl_str_mv Trilla Fuertes, Lucía
Gámez Pozo, Angelo
Lumbreras-Herrera, María Isabel
López-Vacas, Rocío
Heredia-Soto, Victoria
Ghanem, Ismael
López-Camacho, Elena
Zapater-Moros, Andrea
Miguel, María
Pena Burgos, Eva Manuela
Palacios, Elena
de Uribe, Marta
Guerra, Laura
Dittmann, Antje
Mendiola, Marta
Vara, Juan Ángel Fresno
Feliú Batlle, Jaime
author Trilla Fuertes, Lucía
author_facet Trilla Fuertes, Lucía
Gámez Pozo, Angelo
Lumbreras-Herrera, María Isabel
López-Vacas, Rocío
Heredia-Soto, Victoria
Ghanem, Ismael
López-Camacho, Elena
Zapater-Moros, Andrea
Miguel, María
Pena Burgos, Eva Manuela
Palacios, Elena
de Uribe, Marta
Guerra, Laura
Dittmann, Antje
Mendiola, Marta
Vara, Juan Ángel Fresno
Feliú Batlle, Jaime
author_role author
author2 Gámez Pozo, Angelo
Lumbreras-Herrera, María Isabel
López-Vacas, Rocío
Heredia-Soto, Victoria
Ghanem, Ismael
López-Camacho, Elena
Zapater-Moros, Andrea
Miguel, María
Pena Burgos, Eva Manuela
Palacios, Elena
de Uribe, Marta
Guerra, Laura
Dittmann, Antje
Mendiola, Marta
Vara, Juan Ángel Fresno
Feliú Batlle, Jaime
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Departamento de Medicina
Facultad de Medicina
dc.subject.none.fl_str_mv carcinogenesis
high-throughput proteomics
molecular profiles
pancreatic ductal adenocarcinoma
tumor progression
Medicina
topic carcinogenesis
high-throughput proteomics
molecular profiles
pancreatic ductal adenocarcinoma
tumor progression
Medicina
description Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with an overall 5-year survival rate of just 5%. A better understanding of the carcinogenesis processes and the mechanisms of the progression of PDAC is mandatory. Fifty-two PDAC patients treated with surgery and adjuvant therapy, with available primary tumors, normal tissue, preneoplastic lesions (PanIN), and/or lymph node metastases, were selected for the study. Proteins were extracted from small punches and analyzed by LC-MS/MS using data-independent acquisition. Proteomics data were analyzed using probabilistic graphical models, allowing functional characterization. Comparisons between groups were made using linear mixed models. Three proteomic tumor subtypes were defined. T1 (32% of patients) was related to adhesion, T2 (34%) had metabolic features, and T3 (34%) presented high splicing and nucleoplasm activity. These proteomics subtypes were validated in the PDAC TCGA cohort. Relevant biological processes related to carcinogenesis and tumor progression were studied in each subtype. Carcinogenesis in the T1 subtype seems to be related to an increase of adhesion and complement activation node activity, whereas tumor progression seems to be related to nucleoplasm and translation nodes. Regarding the T2 subtype, it seems that metabolism and, especially, mitochondria act as the motor of cancer development. T3 analyses point out that nucleoplasm, mitochondria and metabolism, and extracellular matrix nodes could be involved in T3 tumor carcinogenesis. The identified processes were different among proteomics subtypes, suggesting that the molecular motor of the disease is different in each subtype. These differences can have implications for the development of future tailored therapeutic approaches for each PDAC proteomics subtype
publishDate 2022
dc.date.none.fl_str_mv 2022
2022-05-13
dc.type.none.fl_str_mv research article
http://purl.org/coar/resource_type/c_2df8fbb1
VoR
http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv http://hdl.handle.net/10486/707566
https://dx.doi.org/10.3390/cancers14102414
url http://hdl.handle.net/10486/707566
https://dx.doi.org/10.3390/cancers14102414
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.relation.none.fl_str_mv European Commission http://dx.doi.org/10.13039/501100000780 Horizon 2020 Framework Programme 823839

dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv MDPI
publisher.none.fl_str_mv MDPI
dc.source.none.fl_str_mv reponame:Biblos-e Archivo. Repositorio Institucional de la UAM
instname:Universidad Autónoma de Madrid
instname_str Universidad Autónoma de Madrid
reponame_str Biblos-e Archivo. Repositorio Institucional de la UAM
collection Biblos-e Archivo. Repositorio Institucional de la UAM
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869415660094750720
score 15.300724